Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on April 10, 2025
HiPaaS Inc. Partners with Databricks to Enhance Healthcare Data Interoperability and AI-Powered Insights
EIN Presswire
·
April 10, 2025
New Healthcare Data Integration and Analytics Solution Will Enable Providers and Payers to Leverage AI for Improved Patient Outcomes. PLEASANTON, CA, UNITED STATES, April 10, 2025 /EINPresswire.com/ -- HiPaaS Inc., a leading healthcare-focused EHR …
Comprehensive Physiotherapy Services Now Available at Walkerville Physiotherapy Near Adelaide CBD
EIN Presswire
·
April 10, 2025
ADELAIDE, SOUTH AUSTRALIA, AUSTRALIA, April 11, 2025 /EINPresswire.com/ -- Walkerville Physiotherapy has expanded its range of physiotherapy services, offering comprehensive treatment options for individuals experiencing pain, injury, or mobility issues. …
DigitalXForce to Launch X-ROC and Cutting-Edge Risk Management Solutions at GISEC, RSA, Blackhat and Gartner Conferences
EIN Presswire
·
April 10, 2025
DigitalXForce to Launch X-ROC and Cutting-Edge Risk Management Solutions at GISEC, RSA, Blackhat and Gartner Conferences DALLAS, TX, UNITED STATES, April 10, 2025 /EINPresswire.com/ -- DigitalXForce, a pioneer in real-time, continuous enterprise …
Immuron Travelan® highest sales in history
GlobeNewswire
·
April 10, 2025
Sales Highlights (unaudited): Global Immuron exceeds AUD$5 million in sales in a fiscal year - highest sales in history March 2025 Quarter AUD$1.3 million up 2% on prior year March 2025 Year to Date AUD$5.3 million up 46% on prior year Australia March 2025 …
argenx Announces FDA Approval of VYVGART Hytrulo Prefilled Syringe for Self-Injection in Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy
GlobeNewswire
·
April 10, 2025
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for when and where to receive treatment – at home, while ‘on …
Crinetics Pharmaceuticals Announces April 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 10, 2025
SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of …
Passing of former Chief Executive Officer, Dr. Loressa Cole
GlobeNewswire
·
April 10, 2025
SILVER SPRING, MD, April 10, 2025 (GLOBE NEWSWIRE) -- It is with profound sadness that we share the passing of our former Chief Executive Officer, Loressa Cole, DNP, MBA, RN, NEA-BC, FAAN, FACHE. Loressa was a beloved member of the American Nurses …
Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
GlobeNewswire
·
April 10, 2025
BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day event to foster conversations about new funding models and …
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
GlobeNewswire
·
April 10, 2025
Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its …
Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
April 10, 2025
TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at- …
Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
GlobeNewswire
·
April 10, 2025
SEATTLE, April 10, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease …
BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025
GlobeNewswire
·
April 10, 2025
LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the …
Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings
GlobeNewswire
·
April 10, 2025
WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
GlobeNewswire
·
April 10, 2025
Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan Kozikowski, internationally acclaimed pioneer in the …
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences
GlobeNewswire
·
April 10, 2025
MARIETTA, Ga., April 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will participate in the following industry conferences this quarter to feature the latest scientific and clinical data …
Pour l’autonomisation des femmes et le renforcement du Canada : les trois priorités en matière de politiques qui nous aideront à réaliser des progrès dans le domaine de la santé des femmes au pays
GlobeNewswire
·
April 10, 2025
TORONTO, 10 avr. 2025 (GLOBE NEWSWIRE) -- Notre vision au sein de l’Association canadienne pour l’équité en santé des femmes (ACESF) est celle d’un avenir où toutes les femmes au pays reçoivent les soins de grande qualité qu’elles méritent. Conformément à …
Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
GlobeNewswire
·
April 10, 2025
EXTON, PA, April 10, 2025 (GLOBE NEWSWIRE) -- As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how specialists are currently managing the condition—and where emerging …
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight
GlobeNewswire
·
April 10, 2025
New York, USA, April 10, 2025 (GLOBE NEWSWIRE) -- Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of …
The Guardian Group Announces its STATE OF QME REPORTING 2025: Stakeholder Survey Report
GlobeNewswire
·
April 10, 2025
Santa Ana, Ca, April 10, 2025 (GLOBE NEWSWIRE) -- The Guardian Group, LCC, a leading firm in the medical-legal industry, today released: “STATE OF QME REPORTING 2025 " its annual report that explores the utility and effectiveness of QME Reports throughout …
Credex Healthcare Launches New Staffing Solutions for Credentialing and Enrollment Services Nationwide
GlobeNewswire
·
April 10, 2025
Jacksonville, Fl , April 10, 2025 (GLOBE NEWSWIRE) -- National leader in medical staff credentialing and enrollment solutions, Credex Healthcare, is proud to announce the launch of its Credentialing Staffing Solutions. This scalable staffing service is …